437 related articles for article (PubMed ID: 22507072)
1. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chen CC; Chang NC
Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
[TBL] [Abstract][Full Text] [Related]
2. Effect of N-acetylcysteine on sympathetic hyperinnervation in post-infarcted rat hearts.
Lee TM; Lai PY; Chang NC
Cardiovasc Res; 2010 Jan; 85(1):137-46. PubMed ID: 19696069
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF
Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791
[TBL] [Abstract][Full Text] [Related]
4. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats.
Iyer A; Woodruff TM; Wu MC; Stylianou C; Reid RC; Fairlie DP; Taylor SM; Brown L
J Cardiovasc Pharmacol; 2011 Nov; 58(5):479-86. PubMed ID: 21753735
[TBL] [Abstract][Full Text] [Related]
6. Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy.
Ebrahim Z; Yellon DM; Baxter GF
Pharmacol Res; 2007 Jan; 55(1):42-8. PubMed ID: 17079163
[TBL] [Abstract][Full Text] [Related]
7. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension.
Gómez-Guzmán M; Jiménez R; Sánchez M; Zarzuelo MJ; Galindo P; Quintela AM; López-Sepúlveda R; Romero M; Tamargo J; Vargas F; Pérez-Vizcaíno F; Duarte J
Free Radic Biol Med; 2012 Jan; 52(1):70-9. PubMed ID: 22001745
[TBL] [Abstract][Full Text] [Related]
8. Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats.
Brown L; Ooi SY; Lau K; Sernia C
Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):263-9. PubMed ID: 10779123
[TBL] [Abstract][Full Text] [Related]
9. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
[TBL] [Abstract][Full Text] [Related]
10. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress.
Bhatia J; Tabassum F; Sharma AK; Bharti S; Golechha M; Joshi S; Sayeed Akhatar M; Srivastava AK; Arya DS
Cardiovasc Toxicol; 2011 Sep; 11(3):272-9. PubMed ID: 21748534
[TBL] [Abstract][Full Text] [Related]
11. L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats.
O'Brien D; Chunduri P; Iyer A; Brown L
Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):296-301. PubMed ID: 20041879
[TBL] [Abstract][Full Text] [Related]
12. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats.
Takeda K; Nakata T; Kuwabara T; Itoh H; Yamahara Y; Takesako T; Tanabe S; Sasaki S; Asayama J; Nakagawa M
Blood Press Suppl; 1992; 3():48-52. PubMed ID: 1343289
[TBL] [Abstract][Full Text] [Related]
13. Probucol attenuates atrial autonomic remodeling in a canine model of atrial fibrillation produced by prolonged atrial pacing.
Gong YT; Li WM; Li Y; Yang SS; Sheng L; Yang N; Shan HB; Xue HJ; Liu W; Yang BF; Dong DL; Li BX
Chin Med J (Engl); 2009 Jan; 122(1):74-82. PubMed ID: 19187621
[TBL] [Abstract][Full Text] [Related]
14. Increased O2*- production and upregulation of ETB receptors by sympathetic neurons in DOCA-salt hypertensive rats.
Dai X; Galligan JJ; Watts SW; Fink GD; Kreulen DL
Hypertension; 2004 May; 43(5):1048-54. PubMed ID: 15051669
[TBL] [Abstract][Full Text] [Related]
15. Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chung TH; Lin SZ; Chang NC
J Hypertens; 2014 Apr; 32(4):795-805. PubMed ID: 24463935
[TBL] [Abstract][Full Text] [Related]
16. Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphism.
Karatas A; Hegner B; de Windt LJ; Luft FC; Schubert C; Gross V; Akashi YJ; Gürgen D; Kintscher U; da Costa Goncalves AC; Regitz-Zagrosek V; Dragun D
Hypertension; 2008 Apr; 51(4):1177-83. PubMed ID: 18259006
[TBL] [Abstract][Full Text] [Related]
17. Effect of sildenafil on ventricular arrhythmias in post-infarcted rat hearts.
Lee TM; Chen CC; Chung TH; Chang NC
Eur J Pharmacol; 2012 Sep; 690(1-3):124-32. PubMed ID: 22683410
[TBL] [Abstract][Full Text] [Related]
18. The antihypertensive effect of taurine in DOCA-salt rats.
Fujita T; Sato Y
J Hypertens Suppl; 1984 Dec; 2(3):S563-5. PubMed ID: 6152784
[TBL] [Abstract][Full Text] [Related]
19. Effect of exercise training on liver antioxidant status of deoxycorticosterone acetate salt induced hypertensive rats.
Elhaïmeur F; Courderot-Masuyer C; Nicod L; Bobillier-Chaumont S; Robin S; Richert L; Berthelot A
Can J Physiol Pharmacol; 2003 May; 81(5):469-75. PubMed ID: 12774853
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
Callera GE; Tostes RC; Yogi A; Montezano AC; Touyz RM
Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
